torcetrapib has been researched along with Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McCullough, PA; Shin, HJ | 1 |
| Burnier, M; Vogt, B | 1 |
| Bourne, PE; Chang, RL; Palsson, BØ; Xie, L | 1 |
2 review(s) available for torcetrapib and Kidney Diseases
| Article | Year |
|---|---|
Focus on lipids: high-density lipoprotein cholesterol and its associated lipoproteins in cardiac and renal disease.
Topics: Amides; Apolipoprotein A-I; Benzodiazepines; Black or African American; Cholesterol Ester Transfer Proteins; Cholesterol Esters; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Esters; Heart Diseases; Humans; Hyperlipoproteinemias; Kidney Diseases; Liver; Niacin; Observational Studies as Topic; Oxazolidinones; Prospective Studies; Quinolines; Randomized Controlled Trials as Topic; Risk; Sulfhydryl Compounds; Triglycerides; White People | 2014 |
Aldosterone and cardiovascular risk.
Topics: Aldosterone; Antihypertensive Agents; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Humans; Hyperaldosteronism; Kidney Diseases; Metabolic Syndrome; Obesity; Quinolines | 2009 |
1 other study(ies) available for torcetrapib and Kidney Diseases
| Article | Year |
|---|---|
Drug off-target effects predicted using structural analysis in the context of a metabolic network model.
Topics: Algorithms; Computational Biology; Drug Discovery; Gene Expression Profiling; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Metabolic Networks and Pathways; Metabolomics; Models, Biological; Protein Binding; Proteome; Quinolines; ROC Curve | 2010 |